124 related articles for article (PubMed ID: 14707082)
1. Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility.
Tenzer S; Stoltze L; Schönfisch B; Dengjel J; Müller M; Stevanović S; Rammensee HG; Schild H
J Immunol; 2004 Jan; 172(2):1083-91. PubMed ID: 14707082
[TBL] [Abstract][Full Text] [Related]
2. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.
Toes RE; Nussbaum AK; Degermann S; Schirle M; Emmerich NP; Kraft M; Laplace C; Zwinderman A; Dick TP; Müller J; Schönfisch B; Schmid C; Fehling HJ; Stevanovic S; Rammensee HG; Schild H
J Exp Med; 2001 Jul; 194(1):1-12. PubMed ID: 11435468
[TBL] [Abstract][Full Text] [Related]
3. An algorithm for the prediction of proteasomal cleavages.
Kuttler C; Nussbaum AK; Dick TP; Rammensee HG; Schild H; Hadeler KP
J Mol Biol; 2000 May; 298(3):417-29. PubMed ID: 10772860
[TBL] [Abstract][Full Text] [Related]
4. Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides.
Ehring B; Meyer TH; Eckerskorn C; Lottspeich F; Tampé R
Eur J Biochem; 1996 Jan; 235(1-2):404-15. PubMed ID: 8631360
[TBL] [Abstract][Full Text] [Related]
5. The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides.
Niedermann G; King G; Butz S; Birsner U; Grimm R; Shabanowitz J; Hunt DF; Eichmann K
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8572-7. PubMed ID: 8710912
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes.
Boes B; Hengel H; Ruppert T; Multhaup G; Koszinowski UH; Kloetzel PM
J Exp Med; 1994 Mar; 179(3):901-9. PubMed ID: 8113682
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of two 20S proteasomes from the endoplasmic reticulum of rat liver microsomes.
Hori H; Nembai T; Miyata Y; Hayashi T; Ueno K; Koide T
J Biochem; 1999 Oct; 126(4):722-30. PubMed ID: 10502681
[TBL] [Abstract][Full Text] [Related]
8. Assessment of proteasomal cleavage probabilities from kinetic analysis of time-dependent product formation.
Peters B; Janek K; Kuckelkorn U; Holzhütter HG
J Mol Biol; 2002 May; 318(3):847-62. PubMed ID: 12054828
[TBL] [Abstract][Full Text] [Related]
9. Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity.
Wang EW; Kessler BM; Borodovsky A; Cravatt BF; Bogyo M; Ploegh HL; Glas R
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9990-5. PubMed ID: 10954757
[TBL] [Abstract][Full Text] [Related]
10. Prediction of proteasome cleavage motifs by neural networks.
Keşmir C; Nussbaum AK; Schild H; Detours V; Brunak S
Protein Eng; 2002 Apr; 15(4):287-96. PubMed ID: 11983929
[TBL] [Abstract][Full Text] [Related]
11. PAProC: a prediction algorithm for proteasomal cleavages available on the WWW.
Nussbaum AK; Kuttler C; Hadeler KP; Rammensee HG; Schild H
Immunogenetics; 2001 Mar; 53(2):87-94. PubMed ID: 11345595
[TBL] [Abstract][Full Text] [Related]
12. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
Rock KL; York IA; Goldberg AL
Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
[TBL] [Abstract][Full Text] [Related]
13. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
14. Different proteasome subtypes in a single tissue exhibit different enzymatic properties.
Dahlmann B; Ruppert T; Kuehn L; Merforth S; Kloetzel PM
J Mol Biol; 2000 Nov; 303(5):643-53. PubMed ID: 11061965
[TBL] [Abstract][Full Text] [Related]
15. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.
Sijts AJ; Standera S; Toes RE; Ruppert T; Beekman NJ; van Veelen PA; Ossendorp FA; Melief CJ; Kloetzel PM
J Immunol; 2000 May; 164(9):4500-6. PubMed ID: 10779750
[TBL] [Abstract][Full Text] [Related]
16. Subtypes of 20S proteasomes from skeletal muscle.
Dahlmann B; Ruppert T; Kloetzel PM; Kuehn L
Biochimie; 2001; 83(3-4):295-9. PubMed ID: 11295489
[TBL] [Abstract][Full Text] [Related]
17. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.
Gaczynska M; Rock KL; Goldberg AL
Nature; 1993 Sep; 365(6443):264-7. PubMed ID: 8396732
[TBL] [Abstract][Full Text] [Related]
18. Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysis.
Khattab B; Eiz-Vesper B; Ganser A; Hertenstein B; Blasczyk R
Ann Hematol; 2004 Feb; 83(2):107-13. PubMed ID: 14648025
[TBL] [Abstract][Full Text] [Related]
19. Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines.
Frisan T; Levitsky V; Polack A; Masucci MG
J Immunol; 1998 Apr; 160(7):3281-9. PubMed ID: 9531285
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
